Perceptive Advisors’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-51,500
Closed -$4.91M 142
2020
Q1
$4.91M Hold
51,500
0.13% 78
2019
Q4
$7.48M Hold
51,500
0.15% 74
2019
Q3
$6.86M Buy
+51,500
New +$6.65M 0.18% 65
2018
Q1
Sell
-206,000
Closed -$24.1M 153
2017
Q4
$24.1M Buy
+206,000
New +$23.3M 0.8% 32
2016
Q2
Sell
-161
Closed -$17K 203
2016
Q1
$17K Buy
+161
New +$15.6K ﹤0.01% 164
2015
Q3
Sell
-139,249
Closed -$14.8M 189
2015
Q2
$14.8M Sell
139,249
-46,968
-25% -$5.2M 0.89% 31
2015
Q1
$21.2M Buy
186,217
+27,501
+17% +$3.14M 1.65% 15
2014
Q4
$17.5M Sell
158,716
-101,359
-39% -$10.7M 1.47% 22
2014
Q3
$25.4M Buy
260,075
+10,300
+4% +$1.01M 2.57% 12
2014
Q2
$25.2M Buy
+249,775
New +$24.4M 2.47% 11
2014
Q1
Sell
-20,600
Closed -$1.86M 143
2013
Q4
$1.86M Buy
+20,600
New +$1.78M 0.22% 55

Other funds holding ZBH

Perceptive Advisors's ZBH Position: Q2 2020 in Review

Perceptive Advisors sold out of Zimmer Biomet (ZBH) in Q2 2020, closing a stake of 51,500 shares — an estimated $4.91M sold.

Perceptive Advisors first reported a position in ZBH in Q4 2013 and held it in 11 quarters. The position peaked at $25.4M in Q3 2014. 946 funds tracked by Wall St. Rank hold ZBH as of Q2 2020.

  • Perceptive Advisors reported no remaining Zimmer Biomet position as of Q2 2020 after selling out during the quarter.
  • Perceptive Advisors sold 51,500 Zimmer Biomet shares in Q2 2020, an estimated $4.91M.
  • Perceptive Advisors first reported a position in Zimmer Biomet in Q4 2013 and held it in 11 quarters.
  • Perceptive Advisors's Zimmer Biomet position peaked at $25.4M in Q3 2014.
  • 946 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2020.

Based on Perceptive Advisors's 13F filing for Q2 2020, filed 14 Aug 2020.